September 19, 2016
First Chinese academic textbook on advanced animal-free testing released at Hangzhou alternatives conference
Humane Society International’s research and toxicology team joined more than 500 Chinese and international scientists at the 2nd International Conference on Toxicity Testing & Translational Toxicology, held September 11-14 in Hangzhou, to discuss advancements in 21st century alternatives to animal testing. Hosted by the Chinese Society of Toxicology and the Chinese Environment Mutagen Society with support from industry and HSI, the conference included for the first time in China a training seminar on the development and evaluation of “adverse outcome pathways” (AOP) and their application to advance non-animal testing practice. The event also served as the public launch of the new book Toxicity Testing Strategy in the 21st Century: Principles and Practices, the first academic text of its kind in China, which includes two chapters co-authored by HSI scientists.
Tina Qu, Shanghai-based regulatory affairs advisor to HSI, said: “This conference has brought into focus the significant advances in non-animal toxicology by the scientific communities in China and globally, which have the potential to reshape our current approaches to product safety and risk assessment. The AOP training we coordinated was especially well-received, as it offers a practical platform to leverage Chinese bioscience expertise, helping to bridge efforts in China and other countries toward more efficient development and use of non-animal test methods based on AOPs. We anticipate that China will play an increasingly prominent role in the field of animal testing alternatives with increased international collaboration and regulatory recognition. HSI is thrilled to support accelerating China’s pathway toward animal-free safety testing.”
Although regulatory adoption of internationally recognized non-animal testing methods has been a slow process in China, there are signs of progress, including a recent move by cosmetics authorities to adopt a contemporary animal testing alternative, with additional alternative approaches in the pipeline. This signals that China will increasingly take advantage of achievements of modern in vitro science and work to align its testing approaches with international regulatory frameworks. HSI welcomes this progress and supports continuing efforts to accelerate the shift to 21st century non-animal testing.
With extensive participation of international experts and expanded involvement of governmental research institutions, the conference represents an important milestone in technology communication, regulatory recognition, and pragmatic application of internationally recognized non-animal testing approaches. Please donate to help further our campaign.